TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
88.58
-1.06 (-1.18%)
Aug 14, 2026, 4:00 PM EDT - Market closed
TransMedics Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 668.47 | 605.49 | 441.54 | 241.62 | 93.46 | 30.26 | |
Revenue Growth | 25.82% | 37.13% | 82.74% | 158.53% | 208.83% | 18.03% |
Cost of Revenue | 276.12 | 242.69 | 179.46 | 87.53 | 28.19 | 9.1 |
Gross Profit | 392.35 | 362.81 | 262.08 | 154.09 | 65.27 | 21.16 |
Selling, General & Admin | 218.27 | 185.17 | 168.62 | 119.55 | 69.9 | 38.28 |
Research & Development | 92.47 | 69.06 | 55.97 | 36.06 | 26.81 | 22.3 |
Operating Expenses | 310.74 | 254.22 | 224.59 | 155.61 | 96.71 | 60.59 |
Operating Income | 81.61 | 108.58 | 37.5 | -1.52 | -31.44 | -39.43 |
Interest Expense | -21.24 | -13.78 | -14.41 | -10.79 | -3.73 | -3.87 |
Interest & Investment Income | 12.3 | 11.4 | 13.4 | - | - | - |
Currency Exchange Gain (Loss) | -2.7 | -1 | 0.7 | - | - | -1 |
Other Non Operating Income (Expenses) | 2.59 | 2.32 | -1.41 | 12.85 | -0.43 | 0.12 |
EBT Excluding Unusual Items | 72.55 | 107.52 | 35.78 | 0.54 | -35.59 | -44.18 |
Other Unusual Items | - | - | - | - | -0.58 | - |
Pretax Income | 72.55 | 107.52 | 35.78 | -26.67 | -36.17 | -44.18 |
Income Tax Expense | -79.15 | -82.77 | 0.32 | -1.64 | 0.07 | 0.04 |
Net Income | 151.7 | 190.29 | 35.46 | -25.03 | -36.23 | -44.22 |
Net Income to Common | 151.7 | 190.29 | 35.46 | -25.03 | -36.23 | -44.22 |
Net Income Growth | 111.69% | 436.58% | - | - | - | - |
Shares Outstanding (Basic) | 34 | 34 | 33 | 33 | 30 | 28 |
Shares Outstanding (Diluted) | 38 | 41 | 35 | 33 | 30 | 28 |
Shares Change | 1.53% | 15.12% | 8.30% | 10.02% | 7.02% | 11.80% |
EPS (Basic) | 4.42 | 5.60 | 1.07 | -0.77 | -1.23 | -1.60 |
EPS (Diluted) | 4.01 | 4.87 | 1.01 | -0.77 | -1.23 | -1.60 |
EPS Growth | 98.94% | 382.53% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 79.04 | 133.59 | -80.94 | -164.88 | -57.72 | -32.38 |
Free Cash Flow Per Share | 2.06 | 3.29 | -2.30 | -5.07 | -1.95 | -1.17 |
Gross Margin | 58.69% | 59.92% | 59.36% | 63.77% | 69.84% | 69.92% |
Operating Margin | 12.21% | 17.93% | 8.49% | -0.63% | -33.64% | -130.29% |
Profit Margin | 22.69% | 31.43% | 8.03% | -10.36% | -38.77% | -146.11% |
Free Cash Flow Margin | 11.82% | 22.06% | -18.33% | -68.24% | -61.76% | -107.01% |
EBITDA | 115.63 | 134.47 | 57.25 | 6.66 | -27.96 | -37.61 |
EBITDA Margin | 17.30% | 22.21% | 12.97% | 2.76% | -29.92% | -124.28% |
D&A For EBITDA | 34.02 | 25.89 | 19.76 | 8.18 | 3.48 | 1.82 |
EBIT | 81.61 | 108.58 | 37.5 | -1.52 | -31.44 | -39.43 |
EBIT Margin | 12.21% | 17.93% | 8.49% | -0.63% | -33.64% | -130.29% |
Effective Tax Rate | - | - | 0.88% | - | - | - |
Revenue as Reported | 668.47 | 605.49 | 441.54 | 241.62 | 93.46 | 30.26 |